Maleato De Enalapril Mylan

Enalapril, the active ingredient in Maleato De Enalapril Mylan, is an ACE inhibitor presented as an oral tablet for oral use. It is used to manage hypertension, heart failure, asymptomatic left ventricular dysfunction, and diabetic nephropathy in adult patients.

GNH USA supplies Maleato De Enalapril Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets and supporting timely delivery to healthcare providers.

Enalapril, an ACE inhibitor, is indicated for several cardiovascular and renal conditions.

- Hypertension: lowers blood pressure by reducing vascular resistance. - Heart failure: improves symptoms and reduces hospitalization risk. - Asymptomatic left ventricular dysfunction: slows disease progression. - Diabetic nephropathy: helps preserve kidney function in patients with diabetes.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Cough: persistent dry cough in some patients. - Dizziness: especially after the first dose or dose increase. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Hypotension: especially in volume‑depleted individuals. - Hyperkalemia: mild elevation of serum potassium.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Neutropenia: significant reduction in white blood cells. - Severe hypotension: marked drop in blood pressure causing fainting. - Acute renal failure: sudden loss of kidney function. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy, clinicians should evaluate several safety considerations.

- Monitor blood pressure: adjust dose to avoid excessive hypotension. - Assess renal function: check serum creatinine and eGFR regularly. - Check serum potassium: avoid hyperkalemia, especially with potassium‑sparing agents. - Pregnancy safety: contraindicated in pregnancy (Category D) due to fetal risk. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Enalapril may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Aliskiren: combined use in diabetic patients can increase renal risk. - Lithium: may raise lithium levels, leading to toxicity. - Potassium‑sparing diuretics: increase risk of hyperkalemia.

Moderate Interactions (Monitor Closely): - NSAIDs: can reduce antihypertensive effect and impair renal function. - Rifampin: may lower enalapril plasma concentrations. - Loop or thiazide diuretics: may cause additive hypotensive effect.